-
Many IRBs spend countless hours of review focusing on the consent documents needed for research studies. Are they too technical? Written at too high a level of readability? Too vague? Not extensive enough in their description of potential risks?
-
Reams have been written about the logistical problems of dealing with local IRBs on multisite trials - the delays, the countless changes demanded by individual boards, the overall hassle.
-
IRBs already are attuned to the dangers of therapeutic misconception, in which research subjects confuse research interventions with personalized medical care. Meaningful informed consent explaining clearly the potential risks and benefits of participation in a study is believed to be the best method of combating the problem.
-
-
Older women taking SSRIs had higher rates of hip bone loss compared to both nonusers and TCA users, when measured twice over an average of 5 years.
-
Although anti-reflux surgery seems to be declining in the United States, there are still many such operations undertaken. However, new data make it clear that very few patients are candidates for fundoplication.
-
After a positive coronary CT scan, patients often undergo stress myocardial perfusion scanning, but the relationship between these two tests in relation to prognosis is poorly understood.
-
The FDA has approved a humanized monoclonal antibody for the treatment of paroxymal nocturnal hemoglobinuria (PNH).
-
-
Liver fibrosis from chronic hepatitis C is worse after menopause and less severe in women receiving hormone therapy.
